Join us as we reflect on 2025 and look ahead to 2026. We’ll review key milestones, lessons learned, and what’s coming next for patient education, support, and community initiatives, followed by an open discussion and Q&A.

Stacey Goodman, MD completed her hematology training at the NIH and Vanderbilt University before joining the faculty in 1993. She helped create and lead the Vanderbilt Amyloidosis Multidisciplinary Program (VAMP) until her retirement in 2021. She currently serves as a member of the board of directors at the Amyloidosis Foundation.